Synexa Life Sciences

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

With a team of over 200 staff across three global laboratory locations; Manchester, Turku (Finland) and Cape Town, we provide innovative solutions to support our customers to achieve their clinical milestones.

Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry, ELISpot and Fluorospot) and genomic services to support clinical trials and translational studies.

We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis.

NEWS

Ultralight plane from bottom with blue wave on black. Illustration background, banner with copy space

Earnings

Thanks to Pfizer, Drug Pricing Clouds Begin To Clear as Q3 Earnings Roll Out

J&J reports today, just two weeks after Pfizer secured certainty on tariffs and drug pricing. Analysts expect to hear about plans from the rest of the industry during third period earnings calls.

October 14, 2025

5 min read

Annalee Armstrong

Facade of Novo Nordisk's office in Fremont, California

Manufacturing

Violations at Novo’s Indiana Plant ‘Unacceptable,’ FDA Says

Slapped with the most severe post-inspection classification, the state of Novo Nordisk’s Indiana manufacturing site could pose a problem for clients, including Regeneron and Scholar Rock.

October 14, 2025

2 min read

Tristan Manalac

Deerfield - Circa June 2019: Takeda Pharmaceutical Company. Takeda recently acquired Irish drugmaker Shire I

Artificial intelligence

Takeda Makes $1B+ AI Bet With Nabla to Build Out Early Pipeline

Nabla and Takeda first joined hands in 2022, to push “the boundaries of next-generation biologics discovery,” according to the startup’s CEO Surge Biswas.

October 14, 2025

2 min read

Tristan Manalac

FDA signage at its headquarters in Maryland

Manufacturing

FDA’s PreCheck Proposal a Welcome But Insufficient Step, Company Execs Say

While a new facility setup program aimed at encouraging onshoring received a positive reception at a recent meeting, industry representatives said the current rules on existing production plants are the main regulatory issues facing manufacturing teams.

October 14, 2025

4 min read

Nick Paul Taylor

Gene therapy

Regeneron Readies FDA Run for Hearing Loss Gene Therapy That Could ‘Transform Patients’ Lives’

Regeneron is aiming to file a regulatory application for DB-OTO by the end of the year.

October 13, 2025

2 min read

Tristan Manalac

2006 James Gathany Captured by James Gathany, Centers for Disease Control's biomedical photographer, this 2006 image depicted the exterior of the new "Tom Harkin Global Communications Center", otherwise known as Building 19, located on the organization's Roybal Campus in Atlanta, Georgia. The facility houses the CDC's Information Center/Library, auditoria and meeting halls, which are used to accommodate in-house staff meetings, and national/international conferences hosted by the CDC, and the National Center for Health Marketing's, Division of Creative Services, which includes a full service television broadcast facility. The exhibit area currently features the "Global Symphony", the first of several permanently installed exhibitions, and changing exhibitions that focus on a variety of public health topics. The exhibits in the Center are self-guided, and require no advance reservations. Additional curriculum-based exhibits and programming will be added in the future. Tom Harkin Global Communications Center Exhibit Area Centers for Disease Control and Prevention - 1600 Clifton Road, N.E., Atlanta, Georgia 30333 - Hours: Monday Friday, 9 am 5 pm, except for federal holidays Admission is free - Government-issue photo ID is required for entry. Please note that CDC is a working federal facility and as such does not provide public tours of its campus and laboratories. - For more information please call 404-639-0830.

Government

Chaos at CDC Continues as Hundreds Fired, Rehired

The last few months have been tumultuous for the CDC, which has seen the ouster of Director Susan Monarez and all 17 members of the Advisory Committee on Immunization Practices.

October 13, 2025

2 min read

Tristan Manalac

Stand out from the crowd and different creative idea concepts , Longest light ladder glowing and aiming high to goal target among other short ladders on green background with shadows . 3D rendering.

Cancer

Moderna Claims Early Victory for Cancer Antigen in Melanoma

Moderna’s mRNA-4359, when used with Keytruda, achieves a 24% overall objective response rate in patients with melanoma, with efficacy increasing to 67% in those positive for PD-L1.

October 13, 2025

2 min read

Tristan Manalac

Illustration showing hand sweeping out half of employees

Layoffs

Novo Retreats From Cell Therapy, Axes Hundreds as Restructuring Rolls On

Novo had around 250 employees working on cell therapies, all of whom will be laid off, though a spokesperson declined to reveal which offices and locations will be affected.

October 13, 2025

2 min read

Tristan Manalac